Biogen, Inc. (BIIB)
190.61
+1.62
(+0.86%)
USD |
NASDAQ |
Feb 11, 13:58
Biogen Market Cap : 27.97B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 915.84B |
| Merck & Co., Inc. | 295.29B |
| AbbVie, Inc. | 388.61B |
| Stoke Therapeutics, Inc. | 1.811B |
| Alnylam Pharmaceuticals, Inc. | 42.54B |
Market Cap Related Metrics
| PE Ratio | 21.65 |
| PS Ratio | 2.935 |
| Price to Book Value | 1.532 |
| Price to Free Cash Flow | 14.21 |
| Price | 190.61 |
| Earnings Yield | 4.62% |
| Operating PE Ratio | 11.61 |
| Normalized PE Ratio | 16.42 |